HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $110,354,933 | +83.9% | 969,727 | 0.0% | 0.66% | +68.7% |
| Q3 2022 | $60,016,000 | -34.5% | 969,727 | -15.6% | 0.39% | -24.4% |
| Q2 2022 | $91,605,000 | -3.1% | 1,148,504 | +27.8% | 0.52% | -4.2% |
| Q1 2022 | $94,567,000 | +46.5% | 898,842 | +50.0% | 0.54% | +72.9% |
| Q4 2021 | $64,560,000 | -1.6% | 599,110 | 0.0% | 0.31% | +9.0% |
| Q3 2021 | $65,627,000 | +17.0% | 599,110 | 0.0% | 0.29% | +17.1% |
| Q2 2021 | $56,101,000 | +1.7% | 599,110 | 0.0% | 0.25% | +2.9% |
| Q1 2021 | $55,142,000 | +25.8% | 599,110 | 0.0% | 0.24% | +44.8% |
| Q4 2020 | $43,825,000 | -15.4% | 599,110 | -10.1% | 0.16% | -20.3% |
| Q3 2020 | $51,774,000 | +365.8% | 666,500 | +233.2% | 0.21% | +322.4% |
| Q2 2020 | $11,116,000 | +87.6% | 200,000 | 0.0% | 0.05% | +36.1% |
| Q1 2020 | $5,924,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |